Trade Summary

2 days ago, Gutwerg Ori, serving as SVP, GENERICS at Ani Pharmaceuticals Inc (ANIP), sold 2,772 shares at $79.50 per share, for a total transaction value of $220,374.00. Following this transaction, Gutwerg Ori now holds 78,696 shares of ANIP.

This sale represents a 3.00% decrease in Gutwerg Ori's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, May 12, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 13, 2026, 1 day after the trade was made.

Ani Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.